NAPROXEN (naproxen sodium) by Humanwell Pharmaceutical is cyclooxygenase inhibitors [moa]. Approved for rheumatoid arthritis. First approved in 1993.
Drug data last refreshed 18h ago
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers
A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain
A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain
Worked on NAPROXEN at Humanwell Pharmaceutical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.